Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Supply, Demand and Key Producers, 2023-2029

Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Supply, Demand and Key Producers, 2023-2029

The global Chimeric Antigen Receptor (CAR)-T Cell Therapy market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Chimeric Antigen Receptor (CAR)-T Cell Therapy demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Chimeric Antigen Receptor (CAR)-T Cell Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Chimeric Antigen Receptor (CAR)-T Cell Therapy that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Chimeric Antigen Receptor (CAR)-T Cell Therapy total market, 2018-2029, (USD Million)

Global Chimeric Antigen Receptor (CAR)-T Cell Therapy total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Chimeric Antigen Receptor (CAR)-T Cell Therapy total market, key domestic companies and share, (USD Million)

Global Chimeric Antigen Receptor (CAR)-T Cell Therapy revenue by player and market share 2018-2023, (USD Million)

Global Chimeric Antigen Receptor (CAR)-T Cell Therapy total market by Type, CAGR, 2018-2029, (USD Million)

Global Chimeric Antigen Receptor (CAR)-T Cell Therapy total market by Application, CAGR, 2018-2029, (USD Million)

This reports profiles major players in the global Chimeric Antigen Receptor (CAR)-T Cell Therapy market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Autolus Therapeutics, CARsgen Therapeutics, Juno Therapeutics, Sorrento Therapeutics, bluebird bio, CELGENE CORPORATION, Eureka Therapeutics, Avacta Life Sciences and Calyxt, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Chimeric Antigen Receptor (CAR)-T Cell Therapy market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Market, Segmentation by Type
Abecma
Breyanzi
Kymriah
Tecartus
Yescarta
Others

Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Market, Segmentation by Application
Hospital
Diagnostic Center
Other

Companies Profiled:
Autolus Therapeutics
CARsgen Therapeutics
Juno Therapeutics
Sorrento Therapeutics
bluebird bio
CELGENE CORPORATION
Eureka Therapeutics
Avacta Life Sciences
Calyxt
Celyad Oncology SA
Fortress Biotech
IMMUNE THERAPEUTICS
Gilead Sciences
Novartis AG
Alaunos Therapeutics
Poseida Therapeutics

Key Questions Answered

1. How big is the global Chimeric Antigen Receptor (CAR)-T Cell Therapy market?

2. What is the demand of the global Chimeric Antigen Receptor (CAR)-T Cell Therapy market?

3. What is the year over year growth of the global Chimeric Antigen Receptor (CAR)-T Cell Therapy market?

4. What is the total value of the global Chimeric Antigen Receptor (CAR)-T Cell Therapy market?

5. Who are the major players in the global Chimeric Antigen Receptor (CAR)-T Cell Therapy market?

6. What are the growth factors driving the market demand?